Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) — Long-term Investment Intensity
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) has a Long-term Investment Intensity of 0.3% as of September 2019. Long-term investments of CN¥1.75 Million represent 0.3% of total assets of CN¥525.73 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See 600671 book value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 0.3%, reflecting long-term investments of CN¥1.75 Million against total assets of CN¥525.73 Million CNY. Also explore 600671 current and non-current assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Hangzhou TianMuShan Pharmaceutical Enter market cap and net worth.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.4% | CN¥1.75 Million | CN¥480.62 Million | ▼ 0.0 pp |
| 2017 | 0.4% | CN¥1.75 Million | CN¥450.44 Million | ▼ -2.7 pp |
| 2016 | 3.1% | CN¥9.35 Million | CN¥306.19 Million | ▼ -0.3 pp |
| 2015 | 3.3% | CN¥9.37 Million | CN¥280.38 Million | — |